Imaging biomarker

Results: 302



#Item
1Flyer06-Pharmaco Imaging_MLI_2012-09.pdf

Flyer06-Pharmaco Imaging_MLI_2012-09.pdf

Add to Reading List

Source URL: www.oncodesign.fr

Language: English - Date: 2012-12-18 04:20:40
2Microsoft Word - Danube_Symposium_2016_flyer.docx

Microsoft Word - Danube_Symposium_2016_flyer.docx

Add to Reading List

Source URL: chemie.univie.ac.at

Language: English - Date: 2016-06-21 04:50:54
3In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact:

In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact:

Add to Reading List

Source URL: www.cbmed.org

Language: English - Date: 2016-07-05 08:05:00
4® Pharmimage A bridge between preclinical and clinical pharmacology.

® Pharmimage A bridge between preclinical and clinical pharmacology.

Add to Reading List

Source URL: www.oncodesign.fr

Language: English - Date: 2014-02-14 04:37:03
5p-medicine – Grant Agreement noD13.2 Concrete recommendations and findings on selected challenges in the selected diseases Deliverable NoConcrete recommendations and findings on selected challenges in t

p-medicine – Grant Agreement noD13.2 Concrete recommendations and findings on selected challenges in the selected diseases Deliverable NoConcrete recommendations and findings on selected challenges in t

Add to Reading List

Source URL: p-medicine.eu

Language: English - Date: 2013-02-13 06:22:25
6PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

Add to Reading List

Source URL: www.oncodesign.com

Language: English - Date: 2016-07-12 12:51:48
7MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre

MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre

Add to Reading List

Source URL: www.aptivsolutions.com

Language: English - Date: 2013-08-16 10:39:06
8Science & Society Translational environmental biology: cell biology informing conservation Nikki Traylor-Knowles and Stephen R. Palumbi Department of Biology, Stanford University, Hopkins Marine Station, Pacific Grove,

Science & Society Translational environmental biology: cell biology informing conservation Nikki Traylor-Knowles and Stephen R. Palumbi Department of Biology, Stanford University, Hopkins Marine Station, Pacific Grove,

Add to Reading List

Source URL: palumbi.stanford.edu

Language: English - Date: 2014-04-28 16:50:43
9. IMAGING . BIOMARKERS . PRECLINICAL . PHARMACOLOGY . ONCOLOGY . ONCOCARDIO ASSESSING CARDIOTOXICITY OF ANTICANCER DRUGS

. IMAGING . BIOMARKERS . PRECLINICAL . PHARMACOLOGY . ONCOLOGY . ONCOCARDIO ASSESSING CARDIOTOXICITY OF ANTICANCER DRUGS

Add to Reading List

Source URL: www.oncodesign.fr

Language: English - Date: 2013-07-03 09:03:43
10Why we focus on Cancer Imaging Imaging plays a crucial role in the clinical management of patients with cancer. Both anatomical (CT/MRI) and Molecular imaging (PET/SPECT) modalities provide essential information on the l

Why we focus on Cancer Imaging Imaging plays a crucial role in the clinical management of patients with cancer. Both anatomical (CT/MRI) and Molecular imaging (PET/SPECT) modalities provide essential information on the l

Add to Reading List

Source URL: www.bci.qmul.ac.uk

Language: English - Date: 2016-04-04 11:36:10